CD8A and neoplasm: A growing body of evidence has highlighted the poor immunogenicity of GBM with a paucity of CD8+ CTLs, relative abundance of Foxp3+ regulatory T cells (Tregs), high infiltration of tumor-associated immunosuppressive macrophages and microglia (TAMs), and presence of myeloid-derived suppressor cells (MDSCs) (2–5).